Sanofi Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Entitys Own Equity Instruments
Sanofi (SNYNF) reported Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Entitys Own Equity Instruments of EUR 154.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments · last filed 2026-02-17
| Period end | Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Entitys Own Equity Instruments 6 month | Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Entitys Own Equity Instruments 12 month |
|---|---|---|
| 2025-12-31 | 154.00M EUR 20-F · filed 2026-02-17 | |
| 2025-06-30 | 222.00M EUR 6-K · filed 2025-10-27 | |
| 2024-12-31 | -20.00M EUR 20-F · filed 2026-02-17 | |
| 2024-06-30 | -10.00M EUR 6-K · filed 2025-10-27 | |
| 2023-12-31 | 97.00M EUR 20-F · filed 2026-02-17 | |
| 2023-06-30 | 3.00M EUR 6-K · filed 2024-07-25 | |
| 2022-12-31 | 13.00M EUR 20-F · filed 2025-02-13 | |
| 2022-06-30 | 13.00M EUR 6-K · filed 2023-07-28 | |
| 2021-12-31 | 165.00M EUR 20-F · filed 2024-02-23 | |
| 2021-06-30 | 67.00M EUR 6-K · filed 2022-07-28 | |
| 2020-12-31 | 320.00M EUR 20-F · filed 2023-02-24 | |
| 2020-06-30 | 299.00M EUR 6-K · filed 2021-07-29 | |
| 2019-12-31 | 106.00M EUR 20-F · filed 2022-02-23 | |
| 2019-06-30 | 34.00M EUR 6-K · filed 2020-07-29 | |
| 2018-12-31 | -537.00M EUR 20-F · filed 2021-03-04 | |
| 2017-12-31 | 0.00 EUR 20-F · filed 2020-03-05 |